Excessive Somnolence

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

VP
Vanda PharmaceuticalsWASHINGTON, DC
1 program
1
VSF-173Phase 21 trial
Active Trials
NCT00467441Completed60

Clinical Trials (1)

Total enrollment: 60 patients across 1 trials

NCT00467441Vanda PharmaceuticalsVSF-173

VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

60 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space